| 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|
| Gross margin | -34,8 k € | +82.1% | -193,7 k € | -859.0% | -20,2 k € | |
| EBITDA | -344,9 k € | -64.1% | -210,2 k € | -940.9% | -20,2 k € | |
| Operating profit | -133,7 k € | +69.4% | -436,9 k € | -2063.4% | -20,2 k € | |
| Profit/loss | -143,2 k € | +67.2% | -437,0 k € | -2063.6% | -20,2 k € | |
| Equity | -595,4 k € | -31.7% | -452,2 k € | -2875.5% | -15,2 k € | |
| Total assets | 1,9 M € | +86.7% | 1,0 M € | +17882.8% | 5,6 k € | |
| Cash | 364,3 k € | +286.3% | 94,3 k € | +1786.1% | 5,0 k € | |
| Debts | 2,5 M € | +69.7% | 1,5 M € | +6923.7% | 20,8 k € | |
| Staff | 0,7 | — | — | |||
Source: Belgian Official Gazette
Private limited company · Saint-Josse-ten-Noode · incorporated on 28/10/2022 · 0,7 ETP
Private limited company loss-making in the latest fiscal year. Cash position rising (+286.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Neuraxpharm Belgium is a Private limited company incorporated in 2022. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Saint-Josse-ten-Noode. It employs on average 0,7 ETP workers (FTE).